Rockwell Medical (RMTI) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Rockwell Medical (RMTI) Interest Coverage Ratio Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Rockwell Medical | 29.87 Mn | 5.07 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.87% |
| Mar 31, 2026 | 53.93% |
| Dec 31, 2025 | 48.29% |
| Sep 30, 2025 | 22.17% |
| Jun 30, 2025 | 37.51% |
| Mar 31, 2025 | 32.89% |
| Dec 31, 2024 | 15.04% |
| Sep 30, 2024 | 17.80% |
| Jun 30, 2024 | 15.55% |
| Mar 31, 2024 | 29.02% |
| Sep 30, 2023 | 22.74% |
| Jun 30, 2023 | 20.53% |
| Dec 31, 2022 | 57.56% |
| Dec 31, 2021 | -120.90% |
| Mar 31, 2021 | -1.66% |
| Dec 31, 2020 | -91.14% |
| Dec 31, 2019 | -149.57% |
| Sep 30, 2019 | -26.82% |
| Jun 30, 2019 | -40.17% |
| Mar 31, 2019 | -8.50% |